Categories AlphaGraphs, Earnings, Health Care
Key highlights from Pfizer (PFE) Q2 2020 earnings results
Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today.
Revenues fell 11% to $11.8 billion. The decline was 9% on an operational basis. The top line number saw an impact of 4% from COVID-19, reflecting disruption to wellness visits for patients in the US as well as lower demand for certain products in China.
On a reported basis, net income fell more than 30% to $3.4 billion, or $0.61 per share. On an adjusted basis, net income dropped 3% to $4.4 billion and EPS declined 2% to $0.78.
The company raised its guidance for fiscal year 2020 and now expects revenues to be $48.6-50.6 billion and adjusted EPS to be $2.85-2.95.
Past Performance
Click here to access the transcript for Pfizer Q2 2020 earnings conference call
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
